RELMADA THERAPEUTICS INC's ticker is RLMD and the CUSIP is 75955J402. A total of 1 filers reported holding RELMADA THERAPEUTICS INC in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $438 | +22.0% | 145,999 | 0.0% | 0.00% | – |
| Q2 2023 | $359 | +987.9% | 145,999 | +884.0% | 0.00% | – |
| Q1 2023 | $33 | -17.5% | 14,838 | +28.7% | 0.00% | – |
| Q4 2022 | $40 | -100.0% | 11,527 | +62.3% | 0.00% | – |
| Q3 2022 | $263,000 | -17.0% | 7,101 | -57.5% | 0.00% | – |
| Q2 2022 | $317,000 | +589.1% | 16,699 | +882.3% | 0.00% | – |
| Q1 2022 | $46,000 | – | 1,700 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| VR Adviser, LLC | 853,206 | $30,041,000 | 3.26% |
| COMMODORE CAPITAL LP | 161,565 | $5,689,000 | 2.27% |
| TANG CAPITAL MANAGEMENT LLC | 200,000 | $7,042,000 | 1.98% |
| PARSONS CAPITAL MANAGEMENT INC/RI | 451,412 | $15,894,000 | 1.30% |
| Avoro Capital Advisors LLC | 1,525,000 | $53,695,000 | 0.93% |
| RTW INVESTMENTS, LP | 1,530,717 | $53,897,000 | 0.84% |
| Pegasus Asset Management, Inc. | 26,958 | $949,000 | 0.48% |
| COWEN AND COMPANY, LLC | 166,942 | $5,878,000 | 0.40% |
| Ikarian Capital, LLC | 290,207 | $10,218,000 | 0.34% |
| Spotlight Asset Group, Inc. | 24,565 | $865,000 | 0.32% |